Tower Research Capital LLC (Trc) Hutchmed (China) LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,495 shares of HCM stock, worth $50,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,495
Previous 1,694
106.32%
Holding current value
$50,188
Previous $29,000
134.48%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding HCM
# of Institutions
65Shares Held
6.88MCall Options Held
6.2KPut Options Held
1.1K-
Schroder Investment Management Group London, X02.92MShares$42 Million0.06% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.32MShares$19 Million0.04% of portfolio
-
State Street Corp Boston, MA350KShares$5.02 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.53 Million0.17% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny310KShares$4.45 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.48B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...